---
title: "Nhwa Pharmaceutical's Sulpiride Hydrochloride Tablets Passes Regulatory Consistency Evaluation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268699160.md"
description: "Nhwa Pharmaceutical's Sulpiride Hydrochloride Tablets Passes Regulatory Consistency Evaluation"
datetime: "2025-12-05T03:40:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268699160.md)
  - [en](https://longbridge.com/en/news/268699160.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268699160.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/268699160.md) | [繁體中文](https://longbridge.com/zh-HK/news/268699160.md)


# Nhwa Pharmaceutical's Sulpiride Hydrochloride Tablets Passes Regulatory Consistency Evaluation



### Related Stocks

- [NHWA (002262.CN)](https://longbridge.com/en/quote/002262.CN.md)

## Related News & Research

- [Delphi World Money completes dispatch of postal ballot notice and regulatory newspaper ads](https://longbridge.com/en/news/279034744.md)
- [Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards | BABYF Stock News](https://longbridge.com/en/news/278540973.md)
- [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/en/news/279032574.md)
- [Franco-Nevada (NYSE:FNV) Sees Large Volume Increase Following Strong Earnings](https://longbridge.com/en/news/278761206.md)
- [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/en/news/278461777.md)